Skip to main content
Society for Applied Microbiology
Share this page
Share on Facebook
Share on Twitter
Share on LinkedIn
Environmental Microbiology Lecture 2017
Vaccines for a 21st century society
The EMI lecture 2017 will be held on 13 October 2017 at One Great George Street in London and will be presented by Professor Rino Rappuoli, Chief Scientist & Head of External Research and Development (R&D) at GlaxoSmithKline (GSK) Vaccines.
He is known globally for his work in vaccines and immunology. He co-founded the field of cellular microbiology, a discipline combining cell biology and microbiology, and pioneered the genomic approach to vaccine development known as reverse vaccinology.
Rappuoli led Chiron Corporation's development of adjuvanted influenza vaccines, MENJUGATE(R) conjugate vaccine against meningococcal-C disease and the first recombinant bacterial vaccine against pertussis. Currently, Rappuoli is actively involved in the research and development of further vaccines against meningococcal disease and avian and pandemic influenza.
Major achievements include development of CRM197 used in
, and pneumococcus vaccines; an acellular pertussis vaccine containing a genetically detoxified pertussis toxin; the first conjugate vaccines against meningococcus; MF59 adjuvant for influenza; the meningococcus B genome-derived vaccine.
During his career, he has introduced several novel scientific concepts: genetic detoxification in 1987; cellular microbiology in 1996; reverse vaccinology in 2000; pan-genome in 2005.
The timing of the lecture this year enables it to become part of the Royal Society of Biology’s “
THIS LECTURE IS FREE - Registration closes 6 October 2017
10/13/2017 6:30 PM - 9:00 PM
1 Great George Street Westminster London SW1P 3AA
Keep me signed in
Create a new account